President Biden will not run for re-election during a tumultuous year that will see parts of the country suffer rolling blackouts, the release of an inhaled COVID vaccine and a boycott over driverless cars, a top JPMorgan Chase strategist predicted. Michael Cembalest, who heads the market and investment strategy unit in the Wall Street bank’s…
Updated Jan. 8, 2024 11:17 am ET Travelers on Monday faced heavy flight cancellations by United and Alaska airlines, one of several ripple effects from the weekend grounding of the Boeing 737 MAX 9. United Airlines canceled more than 220 flights, or 8% of flights, Monday, according to flight tracker FlightAware. Alaska Airlines canceled about…
The firm’s founder has earned more than £1bn over four years but campaigners say it is not “fair”.
Boeing’s new 737 MAX-9 is pictured under construction at their production facility in Renton, Washington, Feb. 13, 2017. Jason Redmond | Reuters Boeing‘s plan to get back on solid footing after a series of quality flaws in its bestselling jet suffered a near disaster when a plane panel blew out during an Alaska Airlines flight,…
Apple’s new mixed-reality headset will become available in the U.S. starting Feb. 2, setting the stage for the company’s premium-priced offering to compete in a crowded market. The tech giant’s Vision Pro headset, initially unveiled in June, will be available for pre-sale Jan. 19. It represents Apple’s first major new product in years. Copyright ©2024…
President Biden says the agreement “clears the way” for Congress to avoid a government shutdown.
Newell Brands will slash about 7% of its office roles and pare down its real-estate footprint in an organizational realignment. The Atlanta-based maker of Rubbermaid and Sharpie said it expected to realize annual pretax savings of $65 million to $90 million net of reinvestment, the majority of which is expected this year. Copyright ©2024 Dow…
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx for $28 each was expected have a value of $1.9 billion net of estimated cash required. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved….
Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash for Harpoon, more than double Friday’s closing price of $10.55 for the South San Francisco, Calif., company. Copyright ©2024 Dow Jones & Company, Inc. All Rights…
Your rights explained as residents and businesses count the cost of flood damage.
